- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
April 6, 2022
General
On April 6, 2022, the COVID Advocates Advisory Board (CAAB) and AVAC's Coalition to Accelerate and Support Prevention Research (CASPR) hosted a special webinar on the Ubuntu trial. Led by the COVID-19 Prevention Network (CoVPN), Ubuntu is a landmark COVID-19 vaccine trial in sub-Saharan Africa investigating the efficacy of mRNA vaccines in people living with HIV against the omicron variant.